PDUFA date past, PTC still hasn’t said what the FDA’s verdict was; BioInvent searching for a new CEO
→ So what’s happening with PTC Therapeutics? The PDUFA date for its Duchenne muscular dystrophy drug ataluren came and went yesterday without a peep from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
